Navigating Health Policy Challenges

This chapter explores the bipartisan importance of access to health therapeutics, particularly for Alzheimer's treatment, and the implications of recent FDA layoffs on public health and safety. The discussion highlights how budget cuts and personnel losses may threaten drug approval processes and food safety, emphasizing the need for clear communication and public awareness. Additionally, the chapter addresses the urgency of maintaining a dedicated workforce within federal health agencies to ensure patient safety and effective oversight.